Inflammatory Cells in Renal Injury and Repair

Seminars in Nephrology

Volumn 27, Issue 3, 2007, Pages 250-259

  Ferenbach, David ^a   Kluth, David C ^a   Hughes, Jeremy ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

B cell; dendritic cell; eosinophil; fibrosis; leukocyte; Macrophage; mast cell apoptosis; T cell

Indexed keywords

CLODRONIC ACID; CYCLOPHOSPHAMIDE; RITUXIMAB;

ARTICLE; DENDRITIC CELL; DIABETIC RETINOPATHY; EOSINOPHIL; HUMAN; INFLAMMATORY CELL; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; LEUKOCYTE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAST CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TISSUE REPAIR;

ANIMALS; B-LYMPHOCYTES; DENDRITIC CELLS; FIBROSIS; FORECASTING; HUMANS; INFLAMMATION; KIDNEY; LEUKOCYTES; MACROPHAGES; MODELS, BIOLOGICAL; T-LYMPHOCYTES; WOUND HEALING;

EID: 34249091068     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2007.02.001     Document Type: Article

References (64)

1. Feng L., Xia Y., Yoshimura T., et al. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J Clin Invest 95 (1995) 1009-1017
2. Game D.S., Hernandez-Fuentes M.P., Chaudhry A.N., et al. CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients. J Am Soc Nephrol 14 (2003) 1652-1661
3. Tse W.Y., Nash G.B., Hewins P., et al. ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation. Kidney Int 67 (2005) 130-139
4. Tipping P.G., and Holdsworth S.R. T cells in crescentic glomerulonephritis. J Am Soc Nephrol 17 (2006) 1253-1263
5. Reynolds J., Norgan V.A., Bhambra U., et al. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J Am Soc Nephrol 13 (2002) 359-369
6. Tipping P.G., Huang X.R., Qi M., et al. Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells. Am J Pathol 152 (1998) 1541-1548
7. Rabb H., O'Meara Y.M., Maderna P., et al. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 51 (1997) 1463-1468
8. Burne M.J., Daniels F., El Ghandour A., et al. Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 108 (2001) 1283-1290
9. Burne-Taney M.J., Ascon D.B., Daniels F., et al. B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol 171 (2003) 3210-3215
10. Burne-Taney M.J., Yokota-Ikeda N., and Rabb H. Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury. Am J Transplant 5 (2005) 1186-1193
11. Odobasic D., Kitching A.R., Tipping P.G., et al. CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms. Kidney Int 68 (2005) 584-594
12. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
13. Bagavant H., and Tung K.S. Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis. J Immunol 175 (2005) 944-950
14. Wolf D., Hochegger K., Wolf A.M., et al. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 16 (2005) 1360-1370
15. Salama A.D., Chaudhry A.N., Holthaus K.A., et al. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int 64 (2003) 1685-1694
16. Cavinato R.A., Casiraghi F., Azzollini N., et al. Pretransplant donor peripheral blood mononuclear cells infusion induces transplantation tolerance by generating regulatory T cells. Transplantation 79 (2005) 1034-1039
17. Kreijveld E., Koenen H.J., Hilbrands L.B., et al. Ex vivo expansion of human CD4+ CD25high regulatory T cells from transplant recipients permits functional analysis of small blood samples. J Immunol Methods 314 (2006) 103-113
18. Segundo D.S., Ruiz J.C., Izquierdo M., et al. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Transplantation 82 (2006) 550-557
19. Hochegger K., Wolf D., and Rosenkranz A.R. CD4CD25 regulatory T cells: a new treatment option in glomerulonephritis. Kidney Int 68 (2005) 1898-1899
20. McCurry K.R., Colvin B.L., Zahorchak A.F., et al. Regulatory dendritic cell therapy in organ transplantation. Transpl Int 19 (2006) 525-538
21. Vigna-Perez M., Hernandez-Castro B., Paredes-Saharopulos O., et al. Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther 8 (2006) R83
22. Salama A.D., and Pusey C.D. Drug insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2 (2006) 221-230
23. Cohen C.D., Calvaresi N., Armelloni S., et al. CD20-positive infiltrates in human membranous glomerulonephritis. J Nephrol 18 (2005) 328-333
24. Ruggenenti P., Chiurchiu C., Brusegan V., et al. Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soc Nephrol 14 (2003) 1851-1857
25. Hellmich B., Csernok E., and Gross W.L. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome. Ann N Y Acad Sci 1051 (2005) 121-131
26. Spanou Z., Keller M., Britschgi M., et al. Involvement of drug-specific T cells in acute drug-induced interstitial nephritis. J Am Soc Nephrol 17 (2006) 2919-2927
27. Meleg-Smith S., and Gauthier P.M. Abundance of interstitial eosinophils in renal allografts is associated with vascular rejection. Transplantation 79 (2005) 444-450
28. Emovon O.E., King J.A., Smith S.R., et al. Clinical significance of eosinophils in suspicious or borderline renal allograft biopsies. Clin Nephrol 59 (2003) 367-372
29. Kawasaki Y., Hosoya M., and Suzuki H. Possible pathogenic role of interleukin-5 and eosino cationic protein in Henoch-Schonlein purpura nephritis. Pediatr Int 47 (2005) 512-517
30. Hiromura K., Kurosawa M., Yano S., et al. Tubulointerstitial mast cell infiltration in glomerulonephritis. Am J Kidney Dis 32 (1998) 593-599
31. Morikawa T., Imanishi M., Suzuki H., et al. Mast cell chymase in the ischemic kidney of severe unilateral renovascular hypertension. Am J Kidney Dis 45 (2005) e45-e50
32. Yamada M., Ueda M., Naruko T., et al. Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int 59 (2001) 1374-1381
33. Kanamaru Y., Scandiuzzi L., Essig M., et al. Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis. J Immunol 176 (2006) 5607-5615
34. Mazzoni A., Siraganian R.P., Leifer C.A., et al. Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells. J Immunol 177 (2006) 3577-3581
35. Duffield J.S., Forbes S.J., Constandinou C.M., et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115 (2005) 56-65
36. Duffield J.S., Erwig L.-P., Wei X., et al. Activated macrophages direct apoptosis and suppress mitosis of mesangial cells. J Immunol 164 (2000) 2110-2119
37. Kipari T., Cailhier J.F., Ferenbach D., et al. Nitric oxide is an important mediator of renal tubular epithelial cell death in vitro and in murine experimental hydronephrosis. Am J Pathol 169 (2006) 388-399
38. Holdsworth S., and Tipping P. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest 76 (1985) 1367-1374
39. Ikezumi Y., Hurst L.A., Masaki T., et al. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int 63 (2003) 83-95
40. Duffield J.S., Tipping P.G., Kipari T., et al. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am J Pathol 167 (2005) 1207-1219
41. Lange-Sperandio B., Fulda S., Vandewalle A., et al. Macrophages induce apoptosis in proximal tubule cells. Pediatr Nephrol 18 (2003) 335-341
42. Tesch G.H., Schwarting A., Kinoshita K., et al. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 103 (1999) 73-80
43. Lange-Sperandio B., Cachat F., Thornhill B.A., et al. Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice. Kidney Int 61 (2002) 516-524
44. Lenda D.M., Kikawada E., Stanley E.R., et al. Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol 170 (2003) 3254-3262
45. Jo S.K., Sung S.A., Cho W.Y., et al. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 21 (2006) 1231-1239
46. Furuichi K., Wada T., Iwata Y., et al. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol 14 (2003) 2503-2515
47. Matheson P.J., Dittmer I.D., Beaumont B.W., et al. The macrophage is the predominant inflammatory cell in renal allograft intimal arteritis. Transplantation 79 (2005) 1658-1662
48. Ozdemir B.H., Demirhan B., and Gungen Y. The presence and prognostic importance of glomerular macrophage infiltration in renal allografts. Nephron 90 (2002) 442-446
49. Jose M.D., Ikezumi Y., van Rooijen N., et al. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 76 (2003) 1015-1022
50. Wyburn K., Wu H., Yin J., et al. Macrophage-derived interleukin-18 in experimental renal allograft rejection. Nephrol Dial Transplant 20 (2005) 699-706
51. Jose M.D., Le Meur Y., Atkins R.C., et al. Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant 3 (2003) 294-300
52. Bohle A., Wehrmann M., Bogenschutz O., et al. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 187 (1991) 251-259
53. Furuta T., Saito T., Ootaka T., et al. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 21 (1993) 480-485
54. Sassy-Prigent C., Heudes D., Mandet C., et al. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49 (2000) 466-475
55. Chow F., Ozols E., Nikolic-Paterson D.J., et al. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 65 (2004) 116-128
56. Chow F.Y., Nikolic-Paterson D.J., Ozols E., et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 69 (2006) 73-80
57. Wilson H.M., Stewart K.N., Brown P.A.J., et al. Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol Ther 6 (2002) 710-717
58. Wilson H.M., Chettibi S., Jobin C., et al. Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am J Pathol 167 (2005) 27-37
59. Kluth D.C., Ainslie C.V., Pearce W.P., et al. Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis. J Immunol 166 (2001) 4728-4736
60. Yamagishi H., Yokoo T., Imasawa T., et al. Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy. J Immunol 166 (2001) 609-616
61. Savill J., Dransfield I., Gregory C., et al. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2 (2002) 965-975
62. Robson M.G., Cook H.T., Botto M., et al. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol 166 (2001) 6820-6828
63. Tas S.W., Quartier P., Botto M., et al. Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis 65 (2006) 216-221
64. Duffield J.S., Ware C.F., Ryffel B., et al. Suppression by apoptotic cells defines tumor necrosis factor-mediated induction of glomerular mesangial cell apoptosis by activated macrophages. Am J Pathol 159 (2001) 1397-1404